Real-world clinical characteristics and therapeutic strategies in patients with moderate-to-severe inflammatory bowel disease in Argentina: Data from the RISE-AR study Pablo Andres Olivera; Domingo Balderramo; Juan Sebastian Lasa; Ignacio Zubiaurre; Gustavo Correa; Pablo Lubrano; Orlando Ruffinengo; Martin Yantorno; Astrid Rausch; Gisela Piñero; Andrea Bolomo; Carla Amigo; Jazmin El-Hakeh; Daiana Beatriz Leonardi; Laura Brion; Alicia Sambuelli;

Risk factors for the emergence of multidrug-resistant organisms in liver cirrhosis Luísa Martins Figueiredo; Maria Ana Rafael; Gonçalo Alexandrino; Joana C. Branco; Rita Carvalho; Mariana Nuno Costa; Alexandra Martins;

Suboptimal response to tumor necrosis factor antagonists in inflammatory bowel disease in Latin America: EXPLORE LATAM study Domingo Balderramo; Jesús Yamamoto-Furusho; Enrique Ponce de León; Julio de María; Ignacio Zubiaurre; Silvia Pedreira; Camilo Lis; Laura Brion; Juan A. de Paula;